UK markets close in 7 hours 21 minutes

Hutchison China MediTech Limited (HCM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.54-0.87 (-2.27%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 56.49B
Enterprise value 35.43B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)23.30
Price/book (mrq)6.41
Enterprise value/revenue 319.48
Enterprise value/EBITDA 7-21.23

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 312.08%
S&P500 52-week change 334.98%
52-week high 343.94
52-week low 323.67
50-day moving average 340.25
200-day moving average 332.97

Share statistics

Avg vol (3-month) 3432.58k
Avg vol (10-day) 3175.81k
Shares outstanding 5172.87M
Implied shares outstanding 6N/A
Float 92.61M
% held by insiders 11.41%
% held by institutions 128.89%
Shares short (30 Aug 2021) 41.63M
Short ratio (30 Aug 2021) 47.56
Short % of float (30 Aug 2021) 4N/A
Short % of shares outstanding (30 Aug 2021) 40.94%
Shares short (prior month 29 Jul 2021) 42.06M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -64.05%
Operating margin (ttm)-94.14%

Management effectiveness

Return on assets (ttm)-18.23%
Return on equity (ttm)-24.13%

Income statement

Revenue (ttm)278.57M
Revenue per share (ttm)1.93
Quarterly revenue growth (yoy)37.30%
Gross profit (ttm)-135.32M
EBITDA -255.58M
Net income avi to common (ttm)-178.43M
Diluted EPS (ttm)-1.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)950.45M
Total cash per share (mrq)5.65
Total debt (mrq)36.69M
Total debt/equity (mrq)3.62
Current ratio (mrq)4.41
Book value per share (mrq)5.86

Cash flow statement

Operating cash flow (ttm)-105.01M
Levered free cash flow (ttm)-86.12M